Glycosaminoglycan and proteoglycan inhibit the depolymerization of beta2-microglobulin amyloid fibrils in vitro.
暂无分享,去创建一个
F. Gejyo | K. Hasegawa | H. Naiki | Suguru Yamamoto | Y. Yamaguchi | N. Takahashi | I. Yamaguchi | Kouichi Seto | N. Tsuzuike | M. Seki | H. Suda | Yu Yamaguchi
[1] K. Ohashi,et al. Proteoglycans in haemodialysis-related amyloidosis , 2004, Virchows Archiv.
[2] Sofia Nyström,et al. Transmissibility of systemic amyloidosis by a prion-like mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Hoshino,et al. Mapping the core of the β2-microglobulin amyloid fibril by H/D exchange , 2002, Nature Structural Biology.
[4] K. Ohashi,et al. Affinity Binding of Glycosaminoglycans with β2-Microglobulin , 2002, Nephron.
[5] C. Dobson,et al. A Partially Structured Species of β2-Microglobulin Is Significantly Populated under Physiological Conditions and Involved in Fibrillogenesis* , 2001, The Journal of Biological Chemistry.
[6] D A Smith,et al. Beta(2)-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. , 2001, Journal of molecular biology.
[7] F. Gejyo,et al. Apolipoprotein E inhibits the depolymerization of beta 2-microglobulin-related amyloid fibrils at a neutral pH. , 2001, Biochemistry.
[8] P. Fraser,et al. Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development. , 2001, The Journal of biological chemistry.
[9] F. Gejyo,et al. Extension of Aβ2M amyloid fibrils with recombinant human β2-microglobulin , 2001 .
[10] D. Heinegård,et al. Age-related changes in the synthesis and mRNA expression of decorin and aggrecan in human meniscus and articular cartilage. , 2001, Osteoarthritis and cartilage.
[11] T. Chiba,et al. Transmission of Mouse Senile Amyloidosis , 2001, Laboratory Investigation.
[12] P. Fraser,et al. Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions. , 2000, European journal of biochemistry.
[13] P. Fraser,et al. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. , 1999, European journal of biochemistry.
[14] P. Roughley,et al. Age-related changes in fibromodulin and lumican in human intervertebral discs. , 1999, Spine.
[15] M. Jadoul,et al. Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis. , 1999, Kidney international.
[16] R. Kisilevsky,et al. The Heparin/Heparan Sulfate-binding Site on Apo-serum Amyloid A , 1999, The Journal of Biological Chemistry.
[17] M. Jadoul,et al. Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients. , 1998, Kidney international.
[18] R. Iozzo. Matrix proteoglycans: from molecular design to cellular function. , 1998, Annual review of biochemistry.
[19] M. Judge,et al. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. , 1998, Diabetes.
[20] T. Wight,et al. Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril Stability , 1997 .
[21] K. Ohashi,et al. Ultrastructural organization of hemodialysis-associated beta 2-microglobulin amyloid fibrils. , 1997, Kidney international.
[22] George B. Benedek,et al. Kinetic theory of fibrillogenesis of amyloid β-protein , 1997 .
[23] K. Ohashi,et al. Visceral organ involvement and extracellular matrix changes in β2-microglobulin amyloidosis – a comparative study with systemic AA and AL amyloidosis , 1997, Virchows Archiv.
[24] F. Gejyo,et al. Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's beta-amyloid fibril formation in vitro. , 1997, Biochemistry.
[25] Satoru Suzuki,et al. Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro , 1997 .
[26] R. Iozzo,et al. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. , 1997, Critical reviews in biochemistry and molecular biology.
[27] M. Skinner,et al. Polymerization of normal and intact beta 2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis. , 1996, Kidney international.
[28] A. Hocking,et al. Recombinant Decorin Glycoforms , 1996, The Journal of Biological Chemistry.
[29] R. Strugnell,et al. Eukaryotic Expression of Recombinant Biglycan , 1996, The Journal of Biological Chemistry.
[30] H. Naiki,et al. First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[31] K. Brunden,et al. Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation. , 1995, The Journal of biological chemistry.
[32] H Kresse,et al. Interaction of Biglycan with Type I Collagen (*) , 1995, The Journal of Biological Chemistry.
[33] P. Fraser,et al. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease , 1995, Nature Medicine.
[34] A. Davison. beta 2-microglobulin and amyloidosis: who is at risk? , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[35] G Pogány,et al. The in vitro interaction of proteoglycans with type I collagen is modulated by phosphate. , 1994, Archives of biochemistry and biophysics.
[36] P. Roughley,et al. Changes in the expression of decorin and biglycan in human articular cartilage with age and regulation by TGF-beta. , 1994, Matrix biology : journal of the International Society for Matrix Biology.
[37] P. Roughley,et al. Non-proteoglycan forms of biglycan increase with age in human articular cartilage. , 1993, The Biochemical journal.
[38] P. Lansbury,et al. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.
[39] J. Volanakis,et al. The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. , 1992, Journal of immunology.
[40] M. Skinner,et al. Demonstration of plasma proteinase inhibitors in beta 2-microglobulin amyloid deposits. , 1992, Kidney international.
[41] M. Solé,et al. In vitro spontaneous synthesis of beta 2-microglobulin amyloid fibrils in peripheral blood mononuclear cell culture. , 1992, The American journal of pathology.
[42] K. Ohashi,et al. Cervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column. , 1992, Kidney international.
[43] K. Koch,et al. Dialysis-related amyloidosis. , 1992, Kidney international.
[44] T. Hardingham,et al. Proteoglycans: many forms and many functions , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[45] R. Bramson,et al. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[46] K. Higuchi,et al. Kinetic analysis of amyloid fibril polymerization in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[47] B. Maldague,et al. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis. , 1991, Kidney international.
[48] E. Ruoslahti,et al. Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.
[49] F. Gejyo,et al. Dialysis amyloidosis: current disease concepts and new perspectives for its treatment. , 1990, Contributions to nephrology.
[50] M. Skinner,et al. Glycosaminoglycans of the hemodialysis-associated carpal synovial amyloid and of amyloid-rich tissues and fibrils of heart, liver, and spleen. , 1990, Clinical chemistry.
[51] O. Toupance,et al. Carpal tunnel syndrome and type of dialysis membrane. , 1989, BMJ.
[52] C. Kay,et al. Circular-dichroism studies on two murine serum amyloid A proteins. , 1988, The Biochemical journal.
[53] N. Tuross,et al. Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. , 1987, The Journal of biological chemistry.
[54] B. Frangione,et al. Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[55] F. Gejyo,et al. Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. , 1986, The New England journal of medicine.
[56] M Arakawa,et al. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. , 1985, Biochemical and biophysical research communications.
[57] L. Tang,et al. Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. , 1985, The Journal of biological chemistry.
[58] B. Charra,et al. Carpal tunnel syndrome, shoulder pain and amyloid deposits in long-term haemodialysis patients. , 1985, Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress.